Medicines Control Authority of Zimbabwe: Difference between revisions
CSV import |
CSV import |
||
| Line 26: | Line 26: | ||
{{medicine-stub}} | {{medicine-stub}} | ||
{{No image}} | {{No image}} | ||
__NOINDEX__ | |||
Latest revision as of 18:51, 17 March 2025
Medicines Control Authority of Zimbabwe (MCAZ) is a government agency in Zimbabwe responsible for the regulation and control of medicines and medical devices in the country. It was established under the Medicines and Allied Substances Control Act (Chapter 15:03) and operates under the Ministry of Health and Child Care.
History[edit]
The MCAZ was established in 1997, replacing the previous Drug Control Council. The establishment of the MCAZ was part of a broader effort to strengthen the regulatory control of medicines and medical devices in Zimbabwe.
Functions[edit]
The primary functions of the MCAZ include the evaluation and registration of medicines and medical devices, post-marketing surveillance, and the regulation of clinical trials. The MCAZ also provides information and advice to healthcare professionals and the public on the safe and effective use of medicines.
Evaluation and Registration[edit]
The MCAZ evaluates and registers medicines and medical devices for use in Zimbabwe. This involves assessing the safety, efficacy, and quality of products before they can be marketed in the country.
Post-Marketing Surveillance[edit]
The MCAZ conducts post-marketing surveillance to monitor the safety and efficacy of medicines and medical devices on the market. This includes the collection and analysis of adverse drug reaction reports.
Regulation of Clinical Trials[edit]
The MCAZ regulates clinical trials in Zimbabwe. This involves reviewing and approving trial protocols, monitoring the conduct of trials, and ensuring the ethical treatment of trial participants.
See also[edit]
